These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 25948019)

  • 1. Ring size in cyclic endomorphin-2 analogs modulates receptor binding affinity and selectivity.
    Piekielna J; Kluczyk A; Gentilucci L; Cerlesi MC; Calo' G; Tomböly C; Łapiński K; Janecki T; Janecka A
    Org Biomol Chem; 2015 Jun; 13(21):6039-46. PubMed ID: 25948019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redoubling the ring size of an endomorphin-2 analog transforms a centrally acting mu-opioid receptor agonist into a pure peripheral analgesic.
    Piekielna J; De Marco R; Gentilucci L; Cerlesi MC; Calo' G; Tömböly C; Artali R; Janecka A
    Biopolymers; 2016 May; 106(3):309-17. PubMed ID: 27038094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological characterization of endomorphin-2-based cyclic pentapeptides with methylated phenylalanine residues.
    Perlikowska R; Malfacini D; Cerlesi MC; Calo' G; Piekielna J; Floriot L; Henry T; do-Rego JC; Tömböly C; Kluczyk A; Janecka A
    Peptides; 2014 May; 55():145-50. PubMed ID: 24632335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of mixed MOR/KOR efficacy cyclic opioid peptide analogs with antinociceptive activity after systemic administration.
    Perlikowska R; Piekielna J; Gentilucci L; De Marco R; Cerlesi MC; Calo G; Artali R; Tömböly C; Kluczyk A; Janecka A
    Eur J Med Chem; 2016 Feb; 109():276-86. PubMed ID: 26785295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent side-chain to side-chain cyclized dermorphin analogues containing a carbonyl bridge.
    Filip K; Oleszczuk M; Pawlak D; Wojcik J; Chung NN; Schillerc PW; Izdebski J
    J Pept Sci; 2003 Oct; 9(10):649-57. PubMed ID: 14620130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of cyclic endomorphin-2 analogs.
    Perlikowska R; do-Rego JC; Cravezic A; Fichna J; Wyrebska A; Toth G; Janecka A
    Peptides; 2010 Feb; 31(2):339-45. PubMed ID: 19995587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and opioid activity of side-chain-to-side-chain cyclic dynorphin A-(1-11) amide analogues cyclized between positions 2 and 5. 1. Substitutions in position 3.
    Vig BS; Murray TF; Aldrich JV
    J Med Chem; 2004 Jan; 47(2):446-55. PubMed ID: 14711314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antinociceptive activity of cyclic endomorphin-2 and morphiceptin analogs.
    Janecka A; Fichna J; Kruszynski R; Sasaki Y; Ambo A; Costentin J; do-Rego JC
    Biochem Pharmacol; 2005 Dec; 71(1-2):188-95. PubMed ID: 16288997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
    Ioja E; Tourwé D; Kertész I; Tóth G; Borsodi A; Benyhe S
    Brain Res Bull; 2007 Sep; 74(1-3):119-29. PubMed ID: 17683797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel highly potent mu-opioid receptor antagonist based on endomorphin-2 structure.
    Fichna J; do-Rego JC; Janecki T; Staniszewska R; Poels J; Broeck JV; Costentin J; Schiller PW; Janecka A
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1350-3. PubMed ID: 18207400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid receptor binding characteristics and structure-activity studies of novel tetrapeptides in the TIPP (Tyr-Tic-Phe-Phe) series.
    Ioja E; Tóth G; Benyhe S; Tourwe D; Péter A; Tömböly C; Borsodi A
    Neurosignals; 2005; 14(6):317-28. PubMed ID: 16772734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, Pharmacological Evaluation, and Computational Studies of Cyclic Opioid Peptidomimetics Containing β
    Wtorek K; Lipiński PFJ; Adamska-Bartłomiejczyk A; Piekielna-Ciesielska J; Sukiennik J; Kluczyk A; Janecka A
    Molecules; 2021 Dec; 27(1):. PubMed ID: 35011383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel sst(4)-selective somatostatin (SRIF) agonists. 3. Analogues amenable to radiolabeling.
    Erchegyi J; Waser B; Schaer JC; Cescato R; Brazeau JF; Rivier J; Reubi JC
    J Med Chem; 2003 Dec; 46(26):5597-605. PubMed ID: 14667214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endomorphin analogues with mixed μ-opioid (MOP) receptor agonism/δ-opioid (DOP) receptor antagonism and lacking β-arrestin2 recruitment activity.
    Cai J; Song B; Cai Y; Ma Y; Lam AL; Magiera J; Sekar S; Wyse BD; Ambo A; Sasaki Y; Lazarus LH; Smith MT; Li T
    Bioorg Med Chem; 2014 Apr; 22(7):2208-19. PubMed ID: 24613457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of potent and selective agonists for the human vasopressin V1b receptor based on modifications of [deamino-cys1]arginine vasopressin at position 4.
    Cheng LL; Stoev S; Manning M; Derick S; Pena A; Mimoun MB; Guillon G
    J Med Chem; 2004 Apr; 47(9):2375-88. PubMed ID: 15084136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformation-activity relationships of cyclic dermorphin analogues.
    Wilkes BC; Schiller PW
    Biopolymers; 1990 Jan; 29(1):89-95. PubMed ID: 2158362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of residues 3 and 4 in cyclic tetrapeptide ligand recognition by the kappa-opioid receptor.
    Przydzial MJ; Pogozheva ID; Bosse KE; Andrews SM; Tharp TA; Traynor JR; Mosberg HI
    J Pept Res; 2005 Mar; 65(3):333-42. PubMed ID: 15787963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel sst(4)-selective somatostatin (SRIF) agonists. 2. Analogues with beta-methyl-3-(2-naphthyl)alanine substitutions at position 8.
    Erchegyi J; Penke B; Simon L; Michaelson S; Wenger S; Waser B; Cescato R; Schaer JC; Reubi JC; Rivier J
    J Med Chem; 2003 Dec; 46(26):5587-96. PubMed ID: 14667213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of aromatic amino acid substitutions in the 3-position of cyclic beta-casomorphin analogues on mu-opioid agonist/delta-opioid antagonist properties.
    Schmidt R; Wilkes BC; Chung NN; Lemieux C; Schiller PW
    Int J Pept Protein Res; 1996 Nov; 48(5):411-9. PubMed ID: 8956074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of 2',6'-dimethyl-L-tyrosine (Dmt) on pharmacological activity of cyclic endomorphin-2 and morphiceptin analogs.
    Fichna J; Perlikowska R; Wyrębska A; Gach K; Piekielna J; do-Rego JC; Toth G; Kluczyk A; Janecki T; Janecka A
    Bioorg Med Chem; 2011 Dec; 19(23):6977-81. PubMed ID: 22047797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.